You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
九洲藥業(603456.SH):擬以3400萬美元收購泰華杭州100%的股權
格隆匯 11-23 17:03

格隆匯11月23日丨九洲藥業(603456.SH)公佈,公司(“買方”)於2021年11月23日與Teva Pharmaceutical Investments Singapore Pte. Ltd(泰華新加坡醫藥投資有限公司,以下簡稱“泰華投資”或“交易對方”或“賣方”)簽署《股權轉讓協議》,擬以自籌資金收購交易對方持有的泰華醫藥化工(杭州)有限公司(“泰華杭州”)100%的股權。

預估交易價格約為3400萬美元,最終交易價格將根據標的公司在交割日的資產、負債等情況作相應調整。

公吿稱,標的公司為國際知名醫藥企業Teva集團下屬全資運營的附屬工廠,在生產管理模式、質控體系保障、綠色創新技術等方面均達到國際水準。標的公司的收購融合將進一步提升公司整體運營管理水平;並有利於公司多區域產能佈局,快速提升公司CDMO業務的承接能力,持續推動公司CDMO業務發展,加強公司與國內外客户的業務合作。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account